Skip to main content
. 2005 Oct 19;2005(4):CD001896. doi: 10.1002/14651858.CD001896.pub2

Comparison 3. LUNA versus LPSN.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Pain relief ‐ up to 6 months 1 68 Odds Ratio (M‐H, Fixed, 95% CI) 0.67 [0.17, 2.61]
1.1 Primary dysmenorrhoea 1 68 Odds Ratio (M‐H, Fixed, 95% CI) 0.67 [0.17, 2.61]
2 Pain relief ‐ up to 12 months 1 68 Odds Ratio (M‐H, Fixed, 95% CI) 0.10 [0.03, 0.32]
2.1 Primary dysmenorrhoea 1 68 Odds Ratio (M‐H, Fixed, 95% CI) 0.10 [0.03, 0.32]
3 Adverse effects 1   Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
3.3 Primary dysmenorrhoea 1 68 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.02 [0.01, 0.06]